ArticleTherapeutic advances in neurological disorders2024
Identification of alemtuzumab-suitable multiple sclerosis patients in Slovakia and sequencing of post-alemtuzumab immunomodulatory treatment.
Ema Kantorová et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.